1. Sorafenib in advanced clear-cell renal-cell carcinoma: Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM, TARGET Study Group, Department of Medicine, Institut Gustave Roussy, Villejuif, France

Autor: Trump, Donald L.
Zdroj: In Urologic Oncology: Seminars and Original Investigations 2007 25(5):443-445
Databáze: ScienceDirect
Externí odkaz: